Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Interferon Alpha-2a Biosimilar Market 2018, Forecast to 2023

Publisher Name :
Date: 07-Aug-2018
No. of pages: 129

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

Scope of the Report:

This report focuses on the Interferon Alpha-2a Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.

Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%.

Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017.

South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%.

Market competition is not intense. Roche, Biosidus, Zydus Cadila, Nanogen, Amega Biotech, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Interferon Alpha-2a Biosimilar is expected to grow at a CAGR of roughly -11.2% over the next five years, will reach 190 million US$ in 2023, from 390 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Roche

- Biosidus

- Zydus Cadila

- Nanogen

- Amega Biotech

- Rhein Minapharm Biogenetics

- PROBIOMED

- 3sbio

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Long-lasting Type

- Ordinary Type

Market Segment by Applications, can be divided into

- Hepatitis C

- Hepatitis B

- Other

There are 15 Chapters to deeply display the global Interferon Alpha-2a Biosimilar market.

Chapter 1, to describe Interferon Alpha-2a Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Interferon Alpha-2a Biosimilar, with sales, revenue, and price of Interferon Alpha-2a Biosimilar, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Interferon Alpha-2a Biosimilar, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Interferon Alpha-2a Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Interferon Alpha-2a Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Interferon Alpha-2a Biosimilar Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Interferon Alpha-2a Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Long-lasting Type
1.2.2 Ordinary Type
1.3 Market Analysis by Applications
1.3.1 Hepatitis C
1.3.2 Hepatitis B
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.1.1 Roche Description
2.1.1.2 Roche Headquarter, Main Business and Finance Overview
2.1.2 Roche Interferon Alpha-2a Biosimilar Product Introduction
2.1.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.1.2.2 Interferon Alpha-2a Biosimilar Product Information
2.1.3 Roche Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Roche Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Roche Interferon Alpha-2a Biosimilar Market Share in 2017
2.2 Biosidus
2.2.1 Business Overview
2.2.1.1 Biosidus Description
2.2.1.2 Biosidus Headquarter, Main Business and Finance Overview
2.2.2 Biosidus Interferon Alpha-2a Biosimilar Product Introduction
2.2.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.2.2.2 Interferon Alpha-2a Biosimilar Product Information
2.2.3 Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Biosidus Interferon Alpha-2a Biosimilar Market Share in 2017
2.3 Zydus Cadila
2.3.1 Business Overview
2.3.1.1 Zydus Cadila Description
2.3.1.2 Zydus Cadila Headquarter, Main Business and Finance Overview
2.3.2 Zydus Cadila Interferon Alpha-2a Biosimilar Product Introduction
2.3.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.3.2.2 Interferon Alpha-2a Biosimilar Product Information
2.3.3 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Zydus Cadila Interferon Alpha-2a Biosimilar Market Share in 2017
2.4 Nanogen
2.4.1 Business Overview
2.4.1.1 Nanogen Description
2.4.1.2 Nanogen Headquarter, Main Business and Finance Overview
2.4.2 Nanogen Interferon Alpha-2a Biosimilar Product Introduction
2.4.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.4.2.2 Interferon Alpha-2a Biosimilar Product Information
2.4.3 Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Nanogen Interferon Alpha-2a Biosimilar Market Share in 2017
2.5 Amega Biotech
2.5.1 Business Overview
2.5.1.1 Amega Biotech Description
2.5.1.2 Amega Biotech Headquarter, Main Business and Finance Overview
2.5.2 Amega Biotech Interferon Alpha-2a Biosimilar Product Introduction
2.5.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.5.2.2 Interferon Alpha-2a Biosimilar Product Information
2.5.3 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Amega Biotech Interferon Alpha-2a Biosimilar Market Share in 2017
2.6 Rhein Minapharm Biogenetics
2.6.1 Business Overview
2.6.1.1 Rhein Minapharm Biogenetics Description
2.6.1.2 Rhein Minapharm Biogenetics Headquarter, Main Business and Finance Overview
2.6.2 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product Introduction
2.6.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.6.2.2 Interferon Alpha-2a Biosimilar Product Information
2.6.3 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Market Share in 2017
2.7 PROBIOMED
2.7.1 Business Overview
2.7.1.1 PROBIOMED Description
2.7.1.2 PROBIOMED Headquarter, Main Business and Finance Overview
2.7.2 PROBIOMED Interferon Alpha-2a Biosimilar Product Introduction
2.7.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.7.2.2 Interferon Alpha-2a Biosimilar Product Information
2.7.3 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global PROBIOMED Interferon Alpha-2a Biosimilar Market Share in 2017
2.8 3sbio
2.8.1 Business Overview
2.8.1.1 3sbio Description
2.8.1.2 3sbio Headquarter, Main Business and Finance Overview
2.8.2 3sbio Interferon Alpha-2a Biosimilar Product Introduction
2.8.2.1 Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
2.8.2.2 Interferon Alpha-2a Biosimilar Product Information
2.8.3 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global 3sbio Interferon Alpha-2a Biosimilar Market Share in 2017
3 Global Interferon Alpha-2a Biosimilar Market Competition, by Manufacturer
3.1 Global Interferon Alpha-2a Biosimilar Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Interferon Alpha-2a Biosimilar Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Interferon Alpha-2a Biosimilar Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Interferon Alpha-2a Biosimilar Manufacturer Market Share in 2017
3.4.2 Top 5 Interferon Alpha-2a Biosimilar Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Interferon Alpha-2a Biosimilar Market Analysis by Regions
4.1 Global Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Interferon Alpha-2a Biosimilar Sales by Regions (2013-2018)
4.1.2 Global Interferon Alpha-2a Biosimilar Revenue by Regions (2013-2018)
4.2 North America Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2013-2018)
5 North America Interferon Alpha-2a Biosimilar by Countries, Type, Application and Manufacturers
5.1 North America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Countries
5.1.1 North America Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
5.1.2 North America Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
5.1.3 United States Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
5.1.4 Canada Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
5.1.5 Mexico Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
5.2 North America Interferon Alpha-2a Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Interferon Alpha-2a Biosimilar Sales by Manufacturers (2016-2017)
5.2.2 North America Interferon Alpha-2a Biosimilar Revenue by Manufacturers (2016-2017)
5.3 North America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Interferon Alpha-2a Biosimilar Sales and Sales Share by Type (2013-2018)
5.3.2 North America Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Type (2013-2018)
5.4 North America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Interferon Alpha-2a Biosimilar Sales and Sales Share by Application (2013-2018)
5.4.2 North America Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Application (2013-2018)
6 Europe Interferon Alpha-2a Biosimilar by Countries, Type, Application and Manufacturers
6.1 Europe Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Countries
6.1.1 Europe Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
6.1.2 Europe Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
6.1.3 Germany Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
6.1.4 UK Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
6.1.5 France Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
6.1.6 Russia Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
6.1.7 Italy Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
6.2 Europe Interferon Alpha-2a Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Interferon Alpha-2a Biosimilar Sales by Manufacturers (2016-2017)
6.2.2 Europe Interferon Alpha-2a Biosimilar Revenue by Manufacturers (2016-2017)
6.3 Europe Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Interferon Alpha-2a Biosimilar Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Interferon Alpha-2a Biosimilar Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Interferon Alpha-2a Biosimilar by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
7.1.3 China Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
7.1.4 Japan Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
7.1.5 Korea Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
7.1.6 India Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Interferon Alpha-2a Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Interferon Alpha-2a Biosimilar Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Interferon Alpha-2a Biosimilar Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Interferon Alpha-2a Biosimilar Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Interferon Alpha-2a Biosimilar Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Application (2013-2018)
8 South America Interferon Alpha-2a Biosimilar by Countries, Type, Application and Manufacturers
8.1 South America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Countries
8.1.1 South America Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
8.1.2 South America Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
8.1.3 Brazil Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
8.1.4 Argentina Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
8.1.5 Colombia Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
8.2 South America Interferon Alpha-2a Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Interferon Alpha-2a Biosimilar Sales by Manufacturers (2016-2017)
8.2.2 South America Interferon Alpha-2a Biosimilar Revenue by Manufacturers (2016-2017)
8.3 South America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Interferon Alpha-2a Biosimilar Sales and Sales Share by Type (2013-2018)
8.3.2 South America Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Type (2013-2018)
8.4 South America Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Interferon Alpha-2a Biosimilar Sales and Sales Share by Application (2013-2018)
8.4.2 South America Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Interferon Alpha-2a Biosimilar by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
9.1.4 UAE Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
9.1.5 Egypt Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
9.1.7 South Africa Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Interferon Alpha-2a Biosimilar Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Interferon Alpha-2a Biosimilar Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Interferon Alpha-2a Biosimilar Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Interferon Alpha-2a Biosimilar Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Interferon Alpha-2a Biosimilar Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Interferon Alpha-2a Biosimilar Revenue and Revenue Share by Application (2013-2018)
10 Global Interferon Alpha-2a Biosimilar Market Segment by Type
10.1 Global Interferon Alpha-2a Biosimilar Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Interferon Alpha-2a Biosimilar Sales and Market Share by Type (2013-2018)
10.1.2 Global Interferon Alpha-2a Biosimilar Revenue and Market Share by Type (2013-2018)
10.2 Long-lasting Type Sales Growth and Price
10.2.1 Global Long-lasting Type Sales Growth (2013-2018)
10.2.2 Global Long-lasting Type Price (2013-2018)
10.3 Ordinary Type Sales Growth and Price
10.3.1 Global Ordinary Type Sales Growth (2013-2018)
10.3.2 Global Ordinary Type Price (2013-2018)
11 Global Interferon Alpha-2a Biosimilar Market Segment by Application
11.1 Global Interferon Alpha-2a Biosimilar Sales Market Share by Application (2013-2018)
11.2 Hepatitis C Sales Growth (2013-2018)
11.3 Hepatitis B Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.1 Global Interferon Alpha-2a Biosimilar Sales, Revenue and Growth Rate (2018-2023)
12.2 Interferon Alpha-2a Biosimilar Market Forecast by Regions (2018-2023)
12.2.1 North America Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.2.2 Europe Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.2.3 Asia-Pacific Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.2.4 South America Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.2.5 Middle East and Africa Interferon Alpha-2a Biosimilar Market Forecast (2018-2023)
12.3 Interferon Alpha-2a Biosimilar Market Forecast by Type (2018-2023)
12.3.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Type (2018-2023)
12.3.2 Global Interferon Alpha-2a Biosimilar Market Share Forecast by Type (2018-2023)
12.4 Interferon Alpha-2a Biosimilar Market Forecast by Application (2018-2023)
12.4.1 Global Interferon Alpha-2a Biosimilar Sales Forecast by Application (2018-2023)
12.4.2 Global Interferon Alpha-2a Biosimilar Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Interferon Alpha-2a Biosimilar Picture
Table Product Specifications of Interferon Alpha-2a Biosimilar
Figure Global Interferon Alpha-2a Biosimilar CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Interferon Alpha-2a Biosimilar CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Interferon Alpha-2a Biosimilar by Types in 2017
Figure Long-lasting Type Picture
Table Major Manufacturers of Long-lasting Type
Figure Ordinary Type Picture
Table Major Manufacturers of Ordinary Type
Figure Interferon Alpha-2a Biosimilar Sales Market Share by Applications in 2017
Figure Hepatitis C Picture
Figure Hepatitis B Picture
Figure Other Picture
Figure United States Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure France Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure UK Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure China Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure India Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Interferon Alpha-2a Biosimilar Revenue (Value) and Growth Rate (2013-2023)
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Roche Interferon Alpha-2a Biosimilar Product
Table Roche Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Roche Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Biosidus Headquarter, Established, Main Business and Finance Overview (2017)
Table Biosidus Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Biosidus Interferon Alpha-2a Biosimilar Product
Table Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biosidus Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Biosidus Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Zydus Cadila Headquarter, Established, Main Business and Finance Overview (2017)
Table Zydus Cadila Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Zydus Cadila Interferon Alpha-2a Biosimilar Product
Table Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Zydus Cadila Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Zydus Cadila Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Nanogen Headquarter, Established, Main Business and Finance Overview (2017)
Table Nanogen Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Nanogen Interferon Alpha-2a Biosimilar Product
Table Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Nanogen Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Nanogen Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Amega Biotech Headquarter, Established, Main Business and Finance Overview (2017)
Table Amega Biotech Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Amega Biotech Interferon Alpha-2a Biosimilar Product
Table Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amega Biotech Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Amega Biotech Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Rhein Minapharm Biogenetics Headquarter, Established, Main Business and Finance Overview (2017)
Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product
Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table PROBIOMED Headquarter, Established, Main Business and Finance Overview (2017)
Table PROBIOMED Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table PROBIOMED Interferon Alpha-2a Biosimilar Product
Table PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global PROBIOMED Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global PROBIOMED Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table 3sbio Headquarter, Established, Main Business and Finance Overview (2017)
Table 3sbio Interferon Alpha-2a Biosimilar Production Bases, Sales Regions and Major Competitors
Table 3sbio Interferon Alpha-2a Biosimilar Product
Table 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global 3sbio Interferon Alpha-2a Biosimilar Sales Market Share in 2017
Figure Global 3sbio Interferon Alpha-2a Biosimilar Revenue Market Share in 2017
Table Global Interferon Alpha-2a Biosimilar Sales by Manufacturer (2016-2017)
Figure Global Interferon Alpha-2a Biosimilar Sales Market Share by Manufacturer in 2016
Figure Global Interferon Alpha-2a Biosimilar Sales Market Share by Manufacturer in 2017
Table Global Interferon Alpha-2a Biosimilar Revenue by Manufacturer (2016-2017)
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Manufacturer in 2016
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Manufacturer in 2017
Table Global Interferon Alpha-2a Biosimilar Price by Manufacturer (2016-2017)
Figure Top 3 Interferon Alpha-2a Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Interferon Alpha-2a Biosimilar Manufacturer (Revenue) Market Share in 2017
Figure Global Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Global Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Sales by Regions (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Sales Market Share by Regions (2013-2018)
Table Global Interferon Alpha-2a Biosimilar Revenue by Regions (2013-2018)
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Regions in 2013
Figure Global Interferon Alpha-2a Biosimilar Revenue Market Share by Regions in 2017
Figure North America Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure North America Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Figure South America Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure South America Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Figure North America Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales Market Share by Countries (2013-2018)
Figure North America Interferon Alpha-2a Biosimilar Sales Market Share by Countries in 2013
Figure North America Interferon Alpha-2a Biosimilar Sales Market Share by Countries in 2017
Table North America Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Revenue Market Share by Countries (2013-2018)
Figure North America Interferon Alpha-2a Biosimilar Revenue Market Share by Countries in 2013
Figure North America Interferon Alpha-2a Biosimilar Revenue Market Share by Countries in 2017
Figure United States Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Canada Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Mexico Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales by Manufacturer (2016-2017)
Figure North America Interferon Alpha-2a Biosimilar Sales Market Share by Manufacturer in 2016
Figure North America Interferon Alpha-2a Biosimilar Sales Market Share by Manufacturer in 2017
Table North America Interferon Alpha-2a Biosimilar Revenue by Manufacturer (2016-2017)
Figure North America Interferon Alpha-2a Biosimilar Revenue Market Share by Manufacturer in 2016
Figure North America Interferon Alpha-2a Biosimilar Revenue Market Share by Manufacturer in 2017
Table North America Interferon Alpha-2a Biosimilar Sales by Type (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales Share by Type (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Revenue by Type (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Revenue Share by Type (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales by Application (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Sales Share by Application (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Revenue by Application (2013-2018)
Table North America Interferon Alpha-2a Biosimilar Revenue Share by Application (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Revenue and Growth Rate (2013-2018)
Table Europe Interferon Alpha-2a Biosimilar Sales by Countries (2013-2018)
Table Europe Interferon Alpha-2a Biosimilar Sales Market Share by Countries (2013-2018)
Table Europe Interferon Alpha-2a Biosimilar Revenue by Countries (2013-2018)
Figure Europe Interferon Alpha-2a Biosimilar Revenue Market Share by Countries in 2016
Figure Europe Interferon Alpha-2a Biosimilar Revenue Market Share by Countries in 2017
Figure Germany Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure UK Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure France Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Russia Interferon Alpha-2a Biosimilar Sales and Growth Rate (2013-2018)
Figure Italy Interferon Alpha-2a Biosimilar Sales an
  • Global Addiction Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Drug addiction is a chronic, recurrent disease characterized by the uncontrolled application of an addictive drug. In recent years, the abuse of exogenous opioids (such as morphine and heroin) has become a serious social problem. It does not care about the physical and mental health of the abuser himself. It also has disastrous consequences for families and society. Opioid withdrawal is extremely difficult once it is abused. Scope of the Report: This report focuses ......
  • Global Turmeric Capsules Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 137
    The aromatic root of the turmeric plant has been used for centuries as a treatment for digestive disorders, inflammation, arthritis and infection. Many of turmeric's historic uses are not necessarily supported by scientific evidence. Nevertheless, turmeric supplements are commonly prescribed as a component of modern integrative medicine. early studies suggest that turmeric can promote the health of your joints, blood vessels and digestive tract. Compounds in turmeric capsules may also offer hope......
  • Global Alpha 1 Antitrypsin Deficiency Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 150
    Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma. Scope of the Report: This report focuses on the Alpha 1 Antitrypsin Deficiency Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Alpha Mannosidosis Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 113
    Alpha-mannosidosis is a lifelong multi-systemic progressive disease, with neuromuscular and skeletal deterioration over decades. Scope of the Report: This report focuses on the Alpha Mannosidosis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. There is no cure for congenital alpha-mannosidosis, and in......
  • Global Ambulatory Surgical & Emergency Center Services Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 128
    The Modern Ambulatory Surgical & Emergency Center Services has developed into a large-scale emergency medical technology center and emergency medical science research center integrating treatment and rescue, medical referral, technical guidance and emergency treatment, emergency and intensive care, and can be used for emergency, critical, and critical patients. The implementation of one-stop emergency medical services without transfer was described as the symbol of modern medicine and the patron......
  • Global Anesthesia Gas Blender Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 137
    The anesthesia machine is complex in structure and consists of a gas source, a gas mixing system, an anesthetic gas evaporator, a breathing circuit, a ventilator, an exhaust system, a monitoring system, an information management system, etc., and the user's safety, accuracy, reliability and Ease of use is higher. After more than half a century of development, the function of the anesthesia machine has basically not changed. The development of the gas supply system, the mechanical gas mixing syst......
  • Global Animal Blood Plasma Products and Derivatives Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angi......
  • Global Animal Health Care Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 135
    By 2050, the global population will expand to 9 billion - a two-thirds increase in future animal protein consumption. Population and income growth will bring about an increase in the consumption of animal protein. The growing demand for protein has given producers an opportunity to improve their production and profitability. Jianming's "all-round nutrition" solution meets two basic needs: providing healthy and safe nutrition solutions and maintaining good economic benefits. Scope ......
  • Global Anticancer Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 129
    Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors. Scope of the Report: This report focuses on the Anticancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Simply put, there are chemotherapy drugs and biological age......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs